Post

Virion reports safety data from Phase IB HBV immunotherapy trial

Virion Therapeutics has reported encouraging safety outcomes from the first-in-human Phase IB clinical study of VRON-0200, a checkpoint modifier immunotherapy …

Beckley Psytech reports initial positive data from TRD treatment trial

Beckley Psytech has released initial positive findings from its Phase IIa clinical study of BPL-003 for treating treatment-resistant depression (TRD). The …

89bio wins EMA priority status for MASH candidate pegozafermin

The European Medicine’s Agency (EMA) has granted priority medicines (PRIME) status to 89bio’s pegozafermin, a drug being evaluated to treat …

Pfizer’s Velsipity UK approval raises competition in the ulcerative colitis market

The recent approval of Pfizer’s oral drug, Velsipity (etrasimod), by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for …

Cleerly touts new data for AI cardiovascular software

Digital healthcare company Cleerly has announced that positive data from two studies investigating its AI-QCT ISCHEMIA software device has been …